Product Description: Myr5A peptide is an acylated peptide composed of apolipoprotein A1 (ApoA1) analog peptide 5A peptide coupled to the saturated fatty acid myristate. Myr5A peptide self-assembled into lipid nanostructures can be used to encapsulate anthracycline Doxorubicin (HY-15142A) and Valrubicin (HY-13772) for compound release studies in vitro[1].
Formula: C211H321N47O57
References: [1]Raut S, et al. Probing the assembly of HDL mimetic, drug carrying nanoparticles using intrinsic fluorescence[J]. Journal of Pharmacology and Experimental Therapeutics, 2020, 373(1): 113-121.
Molecular Weight: 4428.09
Research Area: Others
Target: Others